The Equation Series
Menu

Venture Capital · Profile from Venture Capital Research Companion

8VC

Joe Lonsdale's Austin-based firm — the successor to Formation 8 — that turns the Palantir alumni network into a deal-flow and company-building machine, investing across logistics, health care, fintech, bio and, most visibly, defence and the "American industrial base", with flagship funds that grew from ~$300m (2016) to ~$880m (2023).

At a glance

Founded
2015 (as a successor to Formation 8, founded 2011 by Joe Lonsdale, Brian Koo and Jim Kim); first 8VC flagship fund closed March 2016
Founders
Joe Lonsdale (founding GP; co-founder of Palantir, Addepar and OpenGov), with a founding team drawn from Formation 8 (including Jake Medwell and Alex Kolicich, reported)
Headquarters
Austin, Texas (moved from San Francisco in 2020); offices also in San Francisco/Bay Area (verify)
Ownership / structure
Private partnership controlled by Lonsdale (he was the sole GP named on the 2020 Form D, reported); flagship funds plus SPVs and company-building ("8VC Build")
Leadership (2026)
Joe Lonsdale (managing partner); partners reported to include Jake Medwell, Alex Kolicich and Francisco Gimenez (biotech) — verify the current roster
AUM / capital raised
"Over $6bn" committed capital per Lonsdale (2023); flagship funds ~$300m (2016) → ~$640m (2018 and 2021, reported) → ~$880m (2023); ~$1bn fund sought in 2025 filings (close: verify)
Stage focus
Seed through growth ("every stage"), with heavier emphasis on seed and Series A leads and incubation; frequent follow-on via SPVs
Signature investments
Formation 8 era: Oculus, Oscar Health, RelateIQ, Wish, Yello Mobile, Color. 8VC: Anduril, Blend, Hims & Hers, Flexport, Asana, Guardant Health, Mammoth Biosciences, The Boring Company, Saronic. Disappointments: Wish (post-IPO collapse), Blend (post-IPO collapse)

8 deals and moves analysed

Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.

  1. 2013

    Oculus

    Series A

  2. 2013

    Oscar Health

    Early Venture Rounds

  3. 2013

    RelateIQ

    Growth Round

  4. 2014

    Blend

    Early Venture

  5. 2014

    Wish

    Series D

  6. 2017

    Anduril

    Seed / Early Rounds

  7. 2017

    Hims and Hers

    Early Venture

  8. 2022

    Saronic

    Seed